Current portfolio

IVC Evidensia

A leading veterinary services provider in Europe and North America

IVC Evidensia is a leading veterinary services provider in Europe and North America with more than ~2,500 clinics and hospitals across 20 countries. The Company also operates a successful online pet pharmacy.

  • Sector
  • Country
    United Kingdom
  • Responsible Advisor
    Per Franzén
  • Fund
  • Entry

Private Capital

IVC Evidensia

IVC Evidensia

About IVC Evidensia
IVC was established in 2011 in connection with the merger of some of the most reputable pet clinics in the UK. Since then, the Company has grown rapidly through a large number of add-on acquisitions. In February 2017, IVC was combined with Evidensia, creating a European leader. In 2021 IVCE expanded into North America via the merger with VetStrategy, Canada's #1 veterinary services provider.

IVC Evidensia is headquartered in Bristol, UK and operates a decentralized model promoting clinical freedom balanced with integrated support functions such as procurement, veterinary advisors and clinical boards. With its vet-friendly culture and reputation for clinical excellence, IVC Evidensia has quickly grown into the largest veterinary services provider in Europe and Canada with approximately 41,000 employees.

Market Trends and Drivers
The demand for professional pet care has increased significantly over the past years as pets are progressively considered more important family members. With IVC Evidensia's focus on high quality and customer satisfaction, IVC Evidensia is well positioned to provide the best basic care and the most advanced treatments available in the market.

Investment Potential
EQT VII and EQT IX will apply a strategy geared towards further growth which is planned to be achieved both through increased market penetration and continued consolidation across the highly fragmented European and North American market with IVC as the platform. Focus for IVC is to develop its position as a leading provider in terms of quality, being a driving force in improving industry-standards and to continue to provide the best care and the most advanced treatments for pets in Europe and North America.

Board of directors

  • Chairperson
    Kate Swann
  • Board member
    Per Franzén
  • Board member
    Ali Farahani
  • Board member
    Jarl Dahlfors
  • Board member
    Clare Bousfield
  • Board member
    Simon Patterson
  • Board member
    Jeff Hamilton
  • Board member
    Nina L. Krueger
  • Board member
    Chris Hadley


  • CEO
    Simon Smith
  • CFO
    Heine Dalsgaard
EQT logo